Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	125	147	42	15	27	5
Market Cap Growth	72.28%	246.10%	175.83%	-43.79%	420.70%	-50.67%
Enterprise Value	113	142	39	11	22	3
Last Close Price	0.10	0.14	0.05	0.02	0.06	0.03
PS Ratio	36.20	75.34	29.21	52.08	27.69	4.21
PB Ratio	10.81	13.10	11.24	2.02	3.05	1.27
P/TBV Ratio	10.81	13.10	11.24	2.06	3.10	1.32
EV/Sales Ratio	32.79	72.90	26.83	37.85	22.28	2.41
Debt / Equity Ratio	-	-	-	0.02	0.01	0.02
Asset Turnover	0.38	0.21	0.20	0.03	0.11	0.11
Inventory Turnover	-	-	-	-	-	6.68
Quick Ratio	10.82	6.32	3.08	4.05	4.28	0.97
Current Ratio	11.24	6.45	3.22	4.37	4.33	1.01
Return on Equity (ROE)	-85.35%	-116.55%	-178.67%	-103.87%	-76.96%	-46.72%
Return on Assets (ROA)	-45.61%	-59.16%	-73.48%	-47.72%	-28.43%	-22.13%
Return on Capital (ROIC)	-55.88%	-73.93%	-93.48%	-56.45%	-37.23%	-27.84%
Earnings Yield	-5.02%	-5.95%	-23.96%	-55.95%	-18.42%	-188.77%
FCF Yield	-5.24%	-4.79%	-15.06%	-40.91%	-13.54%	-57.47%
Buyback Yield / Dilution	-23.23%	-32.32%	-29.45%	-66.10%	-132.61%	-44.30%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.